WBDE(SZ:002082) Zheng Xing Xing Ye Ri Bao·2025-10-14 08:39Core Insights - The traditional Chinese medicine sector saw a slight increase of 0.43% on October 14, with Wanbangde leading the gains [1] - The Shanghai Composite Index closed at 3865.23, down 0.62%, while the Shenzhen Component Index closed at 12895.11, down 2.54% [1] Stock Performance - Wanbangde (002082) closed at 15.07, up 4.65% with a trading volume of 480,400 shares and a transaction value of 721 million [1] - Tianmu Pharmaceutical (600671) closed at 18.63, up 2.59% with a trading volume of 60,500 shares and a transaction value of 113 million [1] - Qizheng Tibetan Medicine (002287) closed at 26.65, up 1.91% with a trading volume of 61,000 shares and a transaction value of 162 million [1] - Yabao Pharmaceutical (600351) closed at 6.74, up 1.81% with a trading volume of 177,300 shares and a transaction value of 119 million [1] - Other notable performers include Mayinglong (600993) and Shouxiangu (603896), with respective increases of 1.77% and 1.33% [1] Capital Flow - The traditional Chinese medicine sector experienced a net outflow of 183 million from institutional investors, while retail investors saw a net inflow of 272 million [2] - The overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors are more active [2] Individual Stock Capital Flow - Huaren Sanjiu (000999) saw a net inflow of 14.99 million from institutional investors, while Tian Tuli (600535) had a net inflow of 14.64 million [3] - Qizheng Tibetan Medicine (002287) also had a net inflow of 11.14 million from institutional investors, indicating strong interest [3] - Conversely, Zhen Dong Pharmaceutical (300158) faced a significant net outflow of 36.7 million from institutional investors [3]